ERp29 overexpression reportedly inhibits cell proliferation and prevents tumor formation in highly proliferative MDA-MB-231 breast cancer cells, indicating a negative association between ERP29 and cancer cell aggression [40, 41]. This evidence concerns the gene ERP29 and neoplasm.